| Molecular targets of aspirin and cancer prevention L Alfonso, G Ai, RC Spitale, GJ Bhat British journal of cancer 111 (1), 61-67, 2014 | 237 | 2014 |
| Cyclin A2 and CDK2 as novel targets of aspirin and salicylic acid: a potential role in cancer prevention R Dachineni, G Ai, DR Kumar, SS Sadhu, H Tummala, GJ Bhat Molecular Cancer Research 14 (3), 241-252, 2016 | 85 | 2016 |
| Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention BGJ Ai G, Dachineni R, Muley P, Tummala H tumor biology, 2015 | 54* | 2015 |
| Aspirin inhibits glucose‑6‑phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites G Ai, R Dachineni, DR Kumar, LF Alfonso, S Marimuthu, GJ Bhat Molecular Medicine Reports 14 (2), 1726-1732, 2016 | 47 | 2016 |
| Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53 G Ai, R Dachineni, DR Kumar, S Marimuthu, LF Alfonso, GJ Bhat Tumor Biology 37, 6007-6016, 2016 | 39 | 2016 |
| 737MO EpCAM-targeted CAR-T cell therapy in patients with advanced colorectal and gastric cancers W Fang, T Luo, Z Lu, H Zhang, C Tong, S Wang, F Tang, G Ai Annals of Oncology 33, S880-S881, 2022 | 7 | 2022 |
| Aspirin acetylates glucose 6 phosphate dehydrogenase and inhibits its activity in colon cancer cells. G Ai, FK Hagen, JB Gunaje Cancer Research 73 (8_Supplement), 3681-3681, 2013 | 2 | 2013 |
| Regulation of c-Myc expression by aspirin and salicylic acid in colon cancer cells through a novel pathway G Ai, R Dachineni, P Muley, H Tummala, JB Gunaje Cancer Research 75 (15_Supplement), 2093-2093, 2015 | 1 | 2015 |
| Novel cellular targets of aspirin in chemoprevention: Studies on p53, G6PD and c-Myc G Ai South Dakota State University, 2016 | | 2016 |
| Post-translational regulation of cyclins by Aspirin through 26S proteasome: Implications in chemoprevention R Dachineni, G Ai, H Tummala, JB Gunaje Cancer Research 75 (15_Supplement), 1782-1782, 2015 | | 2015 |
| Aspirin modulates oncogene expression in hct 116 colon cancer cells R Dachineni, G Ai, JB Gunaje Cancer Research 74 (19_Supplement), 3501-3501, 2014 | | 2014 |
| Highlight 2 Pharmacogenetics C Potential Use in the Treatment of Human Colon Cancers JB Gunaje, LF Alfonso, G Ai Science 337, 1471-1473, 2012 | | 2012 |
| Highlight 2 Pharmacogenetics Consideration in Aspirin’s Potential Use in the Treatment of Human Colon Cancers JB Gunaje, LF Alfonso, G Ai PGx HIGHLIGHTS 13, 4, 2012 | | 2012 |
